CPIG
TMCI icon

Chicago Partners Investment Group’s Treace Medical Concepts TMCI Stock Holding History

Chicago Partners Investment Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.6K Buy
26,014
+6,606
+34% +$13.2K ﹤0.01% 1423
2025
Q4 		$50.1K Sell
19,408
-377
-2% -$1.64K ﹤0.01% 1280
2025
Q3 		$135K Sell
19,785
-734
-4% -$4.79K ﹤0.01% 1177
2025
Q2 		$125K Sell
20,519
-238
-1% -$1.55K ﹤0.01% 1060
2025
Q1 		$149K Buy
20,757
+1,344
+7% +$12.1K 0.01% 884
2024
Q4 		$147K Buy
19,413
+57
+0.3% +$381 ﹤0.01% 826
2024
Q3 		$98.3K Hold
19,356
– – ﹤0.01% 783
2024
Q2 		$144K Buy
+19,356
New +$156K 0.01% 724

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chicago Partners Investment Group's TMCI Position: Q1 2026 in Review

Chicago Partners Investment Group increased its Treace Medical Concepts (TMCI) stake by 34% in Q1 2026, buying an estimated $13.2K and bringing the position to 26,014 shares worth $48.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Chicago Partners Investment Group first reported a position in TMCI in Q2 2024 and has held it in 8 quarters since. The position peaked at $149K in Q1 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Chicago Partners Investment Group held 26,014 shares of Treace Medical Concepts worth $48.6K as of Q1 2026.
  • Chicago Partners Investment Group bought 6,606 Treace Medical Concepts shares in Q1 2026, an estimated $13.2K.
  • Treace Medical Concepts made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q1 2026, its #1423 holding.
  • Chicago Partners Investment Group first reported a position in Treace Medical Concepts in Q2 2024 and has held it in 8 quarters since.
  • Chicago Partners Investment Group's Treace Medical Concepts position peaked at $149K in Q1 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.